How the DNA tumor virus, simian virus 40, reaches the nucleus is unknown. In this report we have tested the affinity of simian virus 40 toward the nucleus by microinjecting virion particles into the cytoplasm under conditions in which cell-surface-mediated viral infection was blocked. Subcellular localization of viral structural proteins Vpl, Vp2, and Vp3, large tumor antigen, and virion particles was followed immunocytochemically and ultrastructurally. Both virion particles and viral structural proteins localized in the nucleus within 1-2 hr after cytoplasmic injection and subsequently expressed large tumor antigen, which was detected in the nucleus as early as 3 hr after cytoplasmic injection. Vpl and large tumor antigen nuclear accumulation, as well as virion nuclear entry, were blocked by wheat germ agglutinin and an anti-nucleoporin monoclonal antibody, mAb 414. Virion particles were visualized in the vicinity of nuclear pores and in the cytoplasm with this agent. We conclude that virion particles are karyophilic and enter through nuclear pores. This study suggests that vrion structural proteins facilitate virion import into the nucleus and viral gene expression.
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An explanation of how infectious animal viruses reach their virion reproductive site upon cell entry is central to the understanding of virion morphogenesis and the prevention of infectious disease. Papovaviruses adsorb to the cell surface via receptors, where they are internalized in endocytic vesicles; these virion-containing vesicles are reported to be transported across the cytoplasm to the nucleus, the reproductive site of the virion (1) (2) (3) (4) (5) (6) (7) (8) (9) . The surface of the nonenveloped virus is assumed to contain information necessary for targeting the infectious particles to the reproductive site. During normal cell-surface-mediated viral infection, some intracellular virion particles have been found in association with the nuclear fraction as early as 15 min-2 hr of infection, and dissociation of virions into viral structural proteins Vpl, Vp2, and Vp3 and viral DNA occurs there 4-6 hr after infection (2) (3) (4) . This result indicates that a fraction of the infectious particles reaches the nucleus shortly after infection, and uncoating follows thereafter. This relatively short nuclear transit and disassembly time contrasts with the long time seen for commencement of viral gene expression and that seen for intracytoplasmic trafficking of the particles. (i) A long latent period occurs before onset of viral gene expression after viral infection (1, 10) . (it) Most virion particles have been found in many cytoplasmic compartments, including endoplasmic reticulum, lysosomes, and mitochondria for long periods after infection, whereas only a few particles have been seen in the nucleus, both in the nucleoplasm and the intracisternal space of the nuclear envelope (2-4, 5-7). In fact, the latter observation has led to a proposal that the infectious virions enter the nucleus through fusion of the outer nuclear membrane with endocytotic vacuoles containing virion particles (2-4, 7). These observations, however, did not show whether cytologically visualized virion particles are those capable of gene expression and propagation of the infectious cycle.
Reproduction of simian virus 40 (SV40), a member of the papovavirus family, occurs in the nucleus of African green monkey kidney cells (1) . We have mapped the nuclear transport signal (NTS) of Vp2/3 to residues 316-324 of Vp2 and 198-206 of Vp3, GPNKKKRKL (in one-letter code) (11) , which is within a Vp2/3 nuclear localization signal (NLS) (12) . The distinction between an NTS and an NLS is as follows: an NTS can target nonnuclear proteins to the nucleus, whereas an NLS can localize the signal-harboring proteins to the nucleus by undefined means without any NTS activity. The amino-terminal 8 residues of SV40 Vpl contain an NLS (13) but do not promote entry of nonnuclear proteins into the nucleus (14) and, hence, appear insufficient as an NTS. These signals presumably target recently synthesized viral proteins from the cytoplasm to the nucleus for virion assembly. Because a virion particle is composed of these three structural proteins, these signals may also be involved in initially routing infectious virion particles to the reproductive site. In this study we have used microinjection to introduce virion particles directly into the cell cytoplasm to test whether virions, infectious particles, are effectively targeted to the nucleus, and if so, whether they can initiate viral gene expression.
MATERIALS AND METHODS
Cell lines, conditions for cell culture, and preparation of rabbit anti-Vpl and anti-Vp3 sera have been described (15) , as have the procedures for immunofluorescence microscopy and for the use of wheat germ agglutinin (WGA) and Con A (11) . Guinea pig anti-Vpl was prepared as described (15) . SV40 was purified from infected cell lysates as described (16) . The purified virus was centrifuged to equilibrium in CsCl/TD buffer (0.14 M NaCl/5 mM KCl/0.7 mM Na2HPO4/ 2.5 mM Tris HCl, pH 7.5), and the virus band at 1.34 g/cc was collected and stored in the CsCl/TD buffer at -20'C. Concentration of virus was extrapolated from virion protein mass visualized by Coomassie blue staining after NaDodSO4/ PAGE of virion samples compared with known amounts of protein marker(s), as well as from spectrophotometric measurements ofthe sample at 260 and 280 nm (17) . Purified virus preparations contained 1 x 1012 and 1 x 1014 physical particles per ml (corresponding to 1 x 1010 and 1 x 1012 plaque-forming units per ml, assuming 100 physical particles comprise 1 plaque-forming unit). The number of virion particles cytoplasmically microinjected was, unless otherwise noted, from 5 x 102 to 5 x 103 particles for the immunofluorescent studies and from 1 x 104 to 5 x 104 particles for EM studies. Purified monoclonal antibody (mAb) 414 (18) was Abbreviations: NLS, nuclear localization signal; NTS, nuclear transport signal; CGP-BSA, colloidal gold particle-bovine serum albumin; WGA, wheat germ agglutinin; mAb, monoclonal antibody; hpmj, hours post-microinjection; hpmf, hours post-microinfection. *To whom reprint requests should be addressed.
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obtained from David Goldfarb (University of Rochester, Rochester, NY) and was coinjected with virus at 12.5 mg/ml, as was an anti-Escherichia coli B-galactosidase mAb, anti-,B-gal (Promega).
Microinjection of cells was done as described (11) . The microinjection experiments were done, except for those used for EM, with 0.04 ml of virus neutralizing antibody (calf anti-SV40, Flow Laboratories) per ml of the medium. For EM thin sectioning, 5-nm colloidal gold particles (CGP) coupled to bovine serum albumin (BSA) (1 x 1014 particles per ml, Ted Pella, Redding, CA) were included in the microinjection sample. Microinjected cells were marked as an islet by scraping off adjacent and surrounding nonmicroinjected cells with a glass capillary before incubation. A microinfection procedure was developed in which the capillaries were brought close to, but did not touch, the cell surface. The microinfection was done either with or without neutralizing anti-SV40 antibody and cells were cultured in the absence or presence of the antibody, respectively.
For EM, microinjected cell islets were fixed, ethanoldehydrated, and processed for EM thin section as described (19 were found in the proper cell compartments without antiserum. In contrast, with the neutralizing reagent, cell-surfacemediated viral infection was effectively blocked for as long as 24 hr after microinfection, as judged by lack of both gene products ( Fig. 1 B and C) . Consequently, the cytoplasmic microinjection experiments presented here were done, except for the EM study, in the presence of the neutralizing antiserum to block cell-surface-mediated infection. SV40 Particles Are Karyophilic. When virion particles ( Fig.  2A shows the composition of their structural proteins) were directly introduced into the cytoplasm of TC7 cells together with nonnuclear rhodamine-labeled BSA (11) , the major coat protein Vpl accumulated in the nucleus within 2 hr of microinjection [hours post-microinjection (hpmj)] (Fig. 2B) , whereas the rhodamine-BSA remained in the cytoplasm of the same cells (Fig. 2C) . Nuclear Vpl accumulation was seen as early as 1 hpmj and appeared complete by 2 hpmj (Fig. 3  A, C colocalized to the nucleus by 2 hpmj (Fig. 2E )just as did most of the Vpl (Fig. 2D) .
For EM observations cells were microinjected with 5-nm CGP-BSA together with a high concentration of virion particles. In thin sections, the former served as electron-dense markers to distinguish microinjected cells from noninjected cells. An example of the CGP-BSA in a thin section as well as free CGP-BSA is shown in Fig. 4 E and D, respectively. In thin sections, electron-dense particles matched in size to that-of virion particles ( nucleus (1.7 ± 0.7 particles per gtm2) but were scarce in the cytoplasm (0.2 ± 0.4 particles per Am2) at 1.5 hpmj (Fig. 4B ).
These electron-dense particles were not present in noninjected cells (data not shown). Such experiments show that SV40 particles are karyophilic and enter the nucleus shortly after their introduction into the cytoplasm by microinjection.
Virion Nuclear Entry Is Blocked by WGA and mAb 414. Both WGA and mAb 414 bind to the nucleoporin p62 (18) at the central transporter apparatus of the nuclear pore complex (21) and block entry of signal-mediated nuclear proteins (22) (23) (24) . Con A, on the other hand, binds to gp210, which spans the lumen of the nuclear envelope (25-28) and does not inhibit transport (22, 23) . We tested the effect of these reagents on nuclear Vpl accumulation by cytoplasmic comicroinjection of virion particles with each reagent or a control antibody against p-galactosidase. Nuclear Vpl was seen in cells coinjected with either Con A (Fig. 5E control injection (Fig. 5A ). In contrast, in WGA-or mAb 414-coinjected cells, Vpl staining in the nucleus was virtually eliminated and was, instead, seen in the cytoplasm (Fig. 5 C and G). Nuclear accumulation of Vp2/3 was also blocked in cells coinjected with mAb 414, as was Vpl (data not shown).
In agreement with the Vpl immunostaining results, EM confirmed that electron-dense particles were predominantly found in the cytoplasm of mAb 414-coinjected cells (2.6 ± 2.4 particles per Am2, Fig. 4C ). Some electron-dense particles (0.3 ± 0.4 particles per gm2) were also found in transit at the pore (Fig. 4C, arrow, and F) or just inside the inner nuclear membrane (data not shown).
Large Tumor Antigen Expression Accompanies Virion Nuclear Entry. If the virion particles that are artificially introduced into the cytoplasm and that subsequently enter the nucleus are competent for expression of their own genes, production of an early gene product, large tumor antigen, should accompany the nuclear accumulation of Vpl or the particles. This hypothesis was tested by indirect, doubleimmunofluorescent microscopy with anti-Vpl and anti-large tumor antigen serum after cytoplasmic virion microinjection. Nuclear large tumor antigen staining was not seen by 2 hpmj (Fig. 3 B and D) but did appear at 3 and 4 hpmj (Fig. 3 F and  H) . Thus, the viral genomes were present in the nucleus and were transcribed. The large tumor antigen, which is not a virion structural component, was synthesized and localized to the nucleus within 1-2 hr of the virion nuclear entry. Virion-associated Vpl nuclear accumulation preceded viral gene-encoded large tumor antigen accumulation by 2 hr (Fig.  3 A-H) . Furthermore, after cytoplasmic microinjection, large tumor antigen was detected in the nucleus only when Vpl was found there; both WGA and mAb 414, which prevented virion nuclear entry, also prevented large tumor antigen expression (Fig. 5 D and H) , whereas Con A and anti-13-galactosidase, which did not prevent virion nuclear accumulation, allowed large tumor antigen expression (Fig. 5 F and  J) to the same degree as virions alone (Fig. SB) . Thus, cytoplasmically injected virion particles are competent for both nuclear import and viral gene expression.
DISCUSSION
We have established a microinfection assay system in which cell-surface-mediated SV40 infection was efficient but was completely blocked by virus-neutralizing antibody. To assess virion nuclear entry, we then microinjected virion particles directly into the cytoplasm of permissive host cells in the presence of the neutralizing antibody. A significant number of SV40 particles introduced directly into the cytoplasm are karyophilic, enter the nucleus through nuclear pores, and can express an early gene, large tumor antigen, which accumulates in the nucleus of the microinjected cells.
In normal papovavirus infections, virion particles enter the cytoplasm of permissive host cells through the cell surface before they reach the nucleus. The fate of virion particles after infection, as well as the time course of appearance of nuclear large tumor antigen, have been well-documented (1-7, 10, 29, 30) . Despite the fact that the estimated number of virion particles injected into the cytoplasm of a cell in our study is equivalent to that used in reported infection studies, this injection study differs from the reported infection studies (2-7, 10, 29) in two major ways: (i) the shortened time course for nuclear large tumor antigen accumulation and (it) the site of virion nuclear entry. In our cytoplasmic virion microinjection study, nuclear accumulation of all viral structural proteins took 1-2 hr; most electron-dense virion particles were visualized there at 1.5 hpmj, and large tumor antigen accumulation in the nucleus took only 3-4 hr. Because 1-2 hr are required for virions to enter the nucleus, we estimate that -2 hr are necessary for the onset of large tumor antigen gene expression, synthesis, and targeting of the gene product, whereas in viral infection with a multiplicity of infection of -5-10 plaque-forming units, nuclear accumulation of large tumor antigen has been noted to occur at 10-12 hr after infection (10, 29) . A similar time course for nuclear large tumor antigen accumulation has been seen in our cell-surfacemediated microinfection assay system (J.C., unpublished observation). Thus, introduction of the particles directly into the cytoplasm substantially shortens the duration required for the onset of large tumor antigen expression by -7-8 hr. A simple explanation for this difference is difficult. Because the major difference is site of virion delivery, the processes of endocytosis and intracytoplasmic transit could be inefficient or virion particles could be damaged during intracytoplasmic trafficking, resulting in only a small fraction of infectious virion particles reaching the nucleus. Thus, amplification of the viral genome must occur before enough large tumor antigen gene products accumulate for detection.
These observations offer experimental evidence for virion nuclear entry through nuclear pores and contrast with a nuclear-entry route proposed in normal infection; the latter entry assumes that virions enter the nucleus via a fusion event between the outer nuclear membrane and virioncontaining endocytic vesicles that have been transported across the cytoplasm after cell-surface-mediated infection (2) (3) (4) 7) . So Although our results clearly demonstrate entry of infectious virion material through the nuclear pore, this observation does not elucidate any mechanism of transit through the nuclear pore. It is possible that the virion particle changes its shape as it goes through a fully extended and open pore or a partial uncoating of the virus occurs in the cytoplasm so that the individual components can enter through the pore. However, the fact that we see electron-dense virion particles within the nucleus supports our idea that intact virions are traversing the pore. NTS-harboring particles up to 26 nm in diameter have been shown to enter the nucleus through nuclear pores (31, 32) . Therefore, passage of a virion particle with a diameter of -50 nm (1) through a pore must accompany an opening of the channel larger than has been proposed (21, 33). These observations of virion nuclear entry could reflect flexibility of the pore to accommodate incoming particles.
What makes SV40 virion particles karyophilic? As has been shown in both DNA transfection and microinjection experiments, viral DNAs are infectious but appear to require a long latent period for gene expression (29, 34 Although the molar ratio of both Vp2 and Vp3 proteins per particle is less than that of Vpl (36) , this NTS could be exposed at the surface of a virion particle and be accessible to the nuclear pore receptor(s). Unfortunately, the location of Vp2/3 NTS relative to the Vpl chain in the virus has not been identified. Further structural as well as genetic studies may yield information regarding the geometrical configuration of the signal on the virion surface.
